Overview

A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure

Status:
Completed
Trial end date:
2008-01-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and blood pressure lowering effect of different doses of PF-00489791 in patients with mild to moderate high blood pressure
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer